Balance Sheet
AssetsCash & Current InvestmentsCash & EquivalentsCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zepp Health (ZEPP) Receivables - Other (2016 - 2024)

Historic Receivables - Other for Zepp Health (ZEPP) over the last 9 years, with Q4 2024 value amounting to $5.8 million.

  • Zepp Health's Receivables - Other rose 208456.46% to $5.8 million in Q4 2024 from the same period last year, while for Dec 2024 it was $5.8 million, marking a year-over-year increase of 208456.46%. This contributed to the annual value of $5.8 million for FY2024, which is 3486.43% down from last year.
  • Latest data reveals that Zepp Health reported Receivables - Other of $5.8 million as of Q4 2024, which was up 208456.46% from $264858.3 recorded in Q4 2023.
  • Zepp Health's Receivables - Other's 5-year high stood at $141.5 billion during Q2 2021, with a 5-year trough of $264858.3 in Q4 2023.
  • In the last 5 years, Zepp Health's Receivables - Other had a median value of $129.8 million in 2020 and averaged $23.8 billion.
  • Its Receivables - Other has fluctuated over the past 5 years, first surged by 2180302.2% in 2021, then plummeted by 9920.54% in 2022.
  • Zepp Health's Receivables - Other (Quarter) stood at $129.8 million in 2020, then plummeted by 64.38% to $46.2 million in 2021, then tumbled by 99.21% to $367398.5 in 2022, then dropped by 27.91% to $264858.3 in 2023, then skyrocketed by 2084.56% to $5.8 million in 2024.
  • Its Receivables - Other was $5.8 million in Q4 2024, compared to $264858.3 in Q4 2023 and $367398.5 in Q4 2022.